Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Pharmos, Bausch & Lomb expand Lotemax agreement

May 17, 1996

Dorzolamide approved for marketing in Canada

May 17, 1996

AI-300 effective in preliminary clinical study

May 10, 1996

Verteporfin effective in treating severe age-related macular degeneration in early trials

May 3, 1996

Toray's MIP for treatment of ophthalmological disorders

May 3, 1996

EPC-K claimed for ophthalmic use

May 3, 1996

ISV-205 research results presented at vision conference

April 26, 1996

New alpha2-adrenoceptor agonist reported by Allergan

April 12, 1996

FDA approves Laser system for myopia

April 5, 1996

Pharmos completes loteprednol etabonate trial

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
ASH 2025: Tec-dara shines on ‘functional cure’ Majestec-3 MM data
BioWorld
Impressive results of a potential second-line combination treatment for multiple myeloma from the Majestec-3 trial of teclistamab plus daratumumab raised eyebrows...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...